ConsultTheDoc

Modern Minimally Invasive Treatments for Prostate Cancer

Table of Contents

Cryoablation, HIFU, TULSA-Pro, and Irreversible Electroporation

Prostate cancer is one of the most common cancers affecting men worldwide. Traditionally, treatment options have included surgery (radical prostatectomy) or radiation therapy. While these treatments can be very effective, they may also carry risks such as urinary incontinence, erectile dysfunction, and longer recovery times.

In recent years, focal therapy has emerged as an important alternative for select patients. These treatments aim to target and destroy only the cancerous portion of the prostate while preserving surrounding tissue, reducing side effects and improving quality of life.

Several advanced technologies are now being used internationally to achieve this goal, including cryoablation, high-intensity focused ultrasound (HIFU), TULSA-Pro, and irreversible electroporation (IRE).

For patients seeking access to these advanced treatments abroad, HOPE Patient Concierge Services can assist with coordinating care, arranging consultations with leading specialists, and organizing the medical travel process.

Cryoablation (Cryotherapy)

 
 
https://www.researchgate.net/profile/Taimur-Shah/publication/267815333/figure/fig1/AS%3A668228208578568%401536329428527/ce-ball-formation-and-temperature-at-varying-distances-from-probe-Used-with-permission-O.png
 

Cryoablation, also known as cryotherapy, treats prostate cancer by freezing the cancerous tissue.

How it works

Thin probes are inserted into the prostate through the skin between the scrotum and anus (the perineum). Extremely cold gases circulate through the probes, creating an “ice ball” that destroys cancer cells while imaging guidance helps protect surrounding structures.

Key advantages

  • Minimally invasive procedure

  • Usually performed with a short hospital stay

  • Faster recovery compared with traditional surgery

  • Can be used as primary treatment or salvage therapy after radiation failure

Limitations

  • Not appropriate for all prostate cancers

  • Some risk of urinary symptoms or erectile dysfunction remains

Cryoablation is increasingly used for localized prostate cancer, especially when the disease is confined to one area of the gland.

High-Intensity Focused Ultrasound (HIFU)

 
 
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10396-023-01401-z/MediaObjects/10396_2023_1401_Fig1_HTML.png
 

High-Intensity Focused Ultrasound (HIFU) uses concentrated ultrasound waves to generate heat and destroy prostate cancer cells.

How it works

A specialized ultrasound probe is placed in the rectum. The device focuses ultrasound energy precisely on the tumor, raising the temperature of the targeted tissue high enough to destroy cancer cells while preserving nearby structures.

Benefits

  • Non-invasive energy-based therapy

  • No surgical incision

  • Often performed as an outpatient procedure

  • Lower rates of urinary incontinence compared with radical prostatectomy

Ideal candidates

HIFU is typically used for:

  • Localized prostate cancer

  • Patients seeking focal therapy instead of whole-gland treatment

  • Some cases of recurrent cancer after radiation


TULSA-Pro (MRI-Guided Ultrasound Ablation)

https://au.getzhealthcare.com/dev-au-getzhealthcare/products/interventional-oncology/interventional-oncology/ablation/tulsa-pro/image-thumb__14341__ghcProductImagesFull/tulsa-pro-robotic-arm-removed-background%402x.png
https://prostate.radnet.com/static/dedicated-prostate-mri-73261a406852e13eb5a405a82e612c38.jpg
https://www.uclahealth.org/sites/default/files/styles/max_width_009000_360/public/images/TULSA.jpg?itok=EGmPb3It
 

TULSA-Pro (Transurethral Ultrasound Ablation) is one of the most advanced focal therapy technologies currently available.

How it works

Unlike HIFU, which delivers ultrasound from the rectum, TULSA-Pro delivers ultrasound energy from inside the urethra while the patient is inside an MRI scanner. MRI guidance allows physicians to precisely monitor temperature and control treatment in real time.

Key advantages

  • MRI-guided precision

  • Ability to treat part or all of the prostate

  • Real-time temperature monitoring

  • Reduced damage to surrounding tissues

Clinical uses

TULSA-Pro may be used for:

  • Localized prostate cancer

  • Benign prostatic hyperplasia (BPH)

  • Patients seeking minimally invasive alternatives to surgery

Because the procedure is MRI-guided, physicians can map treatment very precisely, potentially preserving erectile function and urinary continence.

Irreversible Electroporation (IRE)

 
https://res.cloudinary.com/broadcastmed/image/fetch/ar_16%3A9%2Cc_fill%2Cg_auto%2Cf_auto%2Cq_auto%2Cw_1300/https%3A%2F%2F55933-bcmed.s3.amazonaws.com%2Fbcp%2Fimages%2FdmImage%2FSourceImage%2Fnano-knife-custom-22.jpg
 
Irreversible Electroporation (IRE)—often known as NanoKnife—is a newer focal therapy that destroys cancer cells using electrical pulses rather than heat or cold.

How it works

Small needles are placed around the tumor within the prostate. Short, high-voltage electrical pulses create tiny pores in the cancer cell membranes, leading to cell death while preserving surrounding connective tissue and nerves.

Benefits

  • Non-thermal therapy (no freezing or heating)

  • May better preserve nerves responsible for erectile function

  • Precise targeting of cancerous areas

  • Minimal scarring of surrounding tissue

Potential role

IRE is particularly promising for tumors located near sensitive structures, where other therapies may risk greater damage.

Expert Care at UChicago Medicine

One of the leading specialists in focal therapy for prostate cancer is Dr. Abhinav Sidana at UChicago Medicine.

Dr. Sidana specializes in advanced prostate cancer treatments and focal therapy techniques, including many of the technologies described above. His work focuses on carefully selecting patients who may benefit from targeted therapy while preserving quality of life.

At major academic centers such as UChicago Medicine, patients often undergo advanced prostate imaging, MRI-targeted biopsies, and multidisciplinary evaluation before determining whether focal therapy is appropriate.

I had the pleasure of meeting him and can say, he is warm, very knowledgeable and passionate about his work and easy to talk to. 

Accessing These Treatments Through HOPE Patient Concierge

Many of these advanced treatments are not widely available in every country, and patients often travel internationally to access them.

HOPE Patient Concierge Services helps simplify this process by:

  • Connecting patients with leading international specialists

  • Coordinating medical record review

  • Arranging consultations and treatment plans

  • Organizing travel, accommodation, and medical appointments

In some cases, patients receive a complete medical itinerary within a few days, allowing them to move quickly from diagnosis to treatment planning.

The Future of Prostate Cancer Treatment

Focal therapy represents an important shift in the treatment of prostate cancer. Instead of removing or radiating the entire prostate, these technologies allow physicians to treat cancer more precisely while preserving quality of life.

While not every patient is a candidate, options such as cryoablation, HIFU, TULSA-Pro, and irreversible electroporation are expanding the range of treatment choices available to men with prostate cancer.

For patients interested in exploring these advanced therapies, working with a specialized medical center—and a concierge service that can coordinate access—may open doors to treatments that were not available locally.

DrAddaeLee
Author: DrAddaeLee

Leave a Reply

Your email address will not be published. Required fields are marked *